Interferon system deficiencies exacerbating severe pandemic virus infections
Autor: | Stertz, Silke, Hale, Benjamin G |
---|---|
Přispěvatelé: | University of Zurich, Hale, Benjamin G |
Rok vydání: | 2021 |
Předmět: |
10028 Institute of Medical Virology
autoantibodies Autoimmunity Severity of Illness Index 2726 Microbiology (medical) Loss of Function Mutation Interferon Pandemic Pathogen Disease Resistance COVID 0303 health sciences 2404 Microbiology interferon 3. Good health Infectious Diseases Virus Diseases Host-Pathogen Interactions Disease Progression disease severity Disease Susceptibility Antibody influenza medicine.drug Microbiology (medical) Opinion 610 Medicine & health Biology Polymorphism Single Nucleotide Microbiology Virus 03 medical and health sciences Immunity Virology medicine Animals Humans Genetic Predisposition to Disease Alleles 030304 developmental biology 030306 microbiology Autoantibody COVID-19 2725 Infectious Diseases Antibodies Neutralizing host genetics Viral replication Immunology 2406 Virology biology.protein pandemic virus 570 Life sciences biology Interferons |
Zdroj: | Trends in Microbiology |
ISSN: | 0966-842X |
DOI: | 10.1016/j.tim.2021.03.001 |
Popis: | Pandemics are caused by novel pathogens to which pre-existing antibody immunity is lacking. Under these circumstances, the body must rely on innate interferon-mediated defenses to limit pathogen replication and allow development of critical humoral protection. Here, we highlight studies on disease susceptibility during H1N1 influenza and COVID-19 (SARS-CoV-2) pandemics. An emerging concept is that genetic and non-genetic deficiencies in interferon system components lead to uncontrolled virus replication and severe illness in a subset of people. Intriguingly, new findings suggest that individuals with autoantibodies neutralizing the antiviral function of interferon are at increased risk of severe COVID-19. We discuss key questions surrounding how such autoantibodies develop and function, as well as the general implications of diagnosing interferon deficiencies for personalized therapies. |
Databáze: | OpenAIRE |
Externí odkaz: |